A claim that “half of patients stop CPAP” is difficult to interpret without knowing who was studied, what counted as use and how missing data were handled. Adherence research is useful, but one headline percentage should not predict an individual person's chances of benefiting from therapy.
Check the definition
One study may count continued use of any duration; another may require a particular number of hours and nights. Average hours can mean hours on nights used or hours across every night, including zero-use nights. Those calculations answer different questions.
Coverage thresholds are also not the same as clinical goals. A person can meet an administrative threshold while leaving part of their sleep untreated. Conversely, being below it does not mean treatment delivered no benefit at all.
Check who is included
A specialist clinic with scheduled support may have different results from a study of everyone offered a device. People who declined treatment, never received equipment or could not be contacted may be included or excluded. A percentage among those still attending follow-up cannot automatically be applied to all patients who started.
Country or city comparisons need comparable methods. Claims that one region is intrinsically better at using CPAP, or that a particular commercial platform fixes adherence, are not justified by an isolated clinic cohort.
Separate association from cause
Early use, comfort and access to support can be associated with later use. That does not prove that a single accessory or a rigid appointment schedule causes the whole improvement. Observational comparisons can be influenced by health, resources, motivation and the quality of clinical care.
Randomised studies can test interventions more directly, but their results still depend on the population, the support offered and the duration of follow-up. An improvement in hours used should also be considered alongside symptoms and other outcomes important to patients.
Turn evidence into a useful question
Ask a service what happens when a person struggles: how fit problems are assessed, whether reports can be reviewed, and how treatment concerns reach the prescribing clinician. Education and troubleshooting are recommended parts of PAP care. Their availability matters more than an unsupported promise that a particular device guarantees adherence.
For your own treatment, compare progress with your sleep needs and agreed clinical goals. Published averages describe groups; they are not a deadline, a judgement about effort, or a reason to give up when the first nights are difficult.
Related reading: Using CPAP throughout sleep: why four hours is not the goal